Betaine homocysteine methyltransferase: Gene cloning and expression analysis in rat liver cirrhosis

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1638, Issue 1, 2003, Pages 29-34

  Forestier, Marc ^a,b   Bänninger, Reto ^a   Reichen, Jürg ^a   Solioz, Marc ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Betaine homocysteine methyltransferase; Differential display; Expression; Gene regulation

Indexed keywords

BETAINE HOMOCYSTEINE METHYLTRANSFERASE; HOMOCYSTEINE; METHYLTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT LIGATION; BLOOD LEVEL; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; DNA LIBRARY; DNA SCREENING; DOWN REGULATION; ENZYME ACTIVITY; ENZYME ASSAY; GENE EXPRESSION; LIVER CIRRHOSIS; LIVER HOMOGENATE; MALE; MOLECULAR CLONING; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

ANIMALIA;

EID: 0037987813     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4439(03)00037-1     Document Type: Article

References (35)

1. Liang P., Averboukh L., Keyomarsi K., Sager R., Pardee A.B. Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells. Cancer Res. 52:1992;6966-6968.
2. Forestier M., Reichen J., Solioz M. Application of mRNA differential display to liver cirrhosis: reduced fetuin expression in biliary cirrhosis in the rat. Biochem. Biophys. Res. Commun. 225:1996;377-383.
3. Landmann L. Cholestasis-induced alterations of the trans- and paracellular pathways in rat hepatocytes. Histochem. Cell Biol. 103:1995;3-9.
4. Wasser S., Tan C.E. Experimental models of hepatic fibrosis in the rat. Ann. Acad. Med. Singap. 28:1999;109-111.
5. Bingham C., Roberts D., Hamilton T.C. The role of molecular biology in understanding ovarian cancer initiation and progression. Int. J. Gynecol. Cancer. 11(Suppl. 1):2001;7-11.
6. Garrow T.A. Purification, kinetic properties, and cDNA cloning of mammalian betaine-homocysteine methyltransferase. J. Biol. Chem. 271:1996;22831-22838.
7. Kountouras J., Billing B.H., Scheuer P.J. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br. J. Exp. Pathol. 65:1984;305-311.
8. Gross J.B. Jr., Reichen J., Zeltner T.B., Zimmermann A. The evolution of changes in quantitative liver function tests in a rat model of biliary cirrhosis: correlation with morphometric measurement of hepatocyte mass. Hepatology. 7:1987;457-463.
9. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
10. Bissig M., Hagenbuch B., Stieger B., Koller T., Meier P.J. Functional expression cloning of the canalicular sulfate transport system of rat hepatocytes. J. Biol. Chem. 269:1994;3017-3021.
11. Ausubel R.M., Brent R., Kingston R.E., Moore D.D., Smith J.A., Struhl K. Current Protocols in Molecular Biology. 1995;Wiley, New York.
12. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
13. Rave N.R., Crkvenjakov X., Boedtker H. Identification of procollagen mRNAs transferred to diazobenzyloxmethyl paper form formaldehyde agarose gels. Nucleic Acids Res. 6:1979;3559.
14. Dakin H.D. The formation of betaine from hydroxyamino acids on methylation. J. Biol. Chem. 140:1941;847-852.
15. Liang P., Pardee A.B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 257:1992;967-971.
16. Auberger P., Falquerho L., Contreres J.O., Pages G., Le Cam G., Rossi B., Le Cam A. Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity. Cell. 58:1989;631-640.
17. Chadwick L.H., McCandless S.E., Silverman G.L., Schwartz S., Westaway D., Nadeau J.H. Betaine-homocysteine methyltransferase-2: cDNA cloning, gene sequence, physical mapping, and expression of the human and mouse genes. Genomics. 70:2000;66-73.
18. Sowden M.P., Collins H.L., Smith H.C., Garrow T.A., Sparks J.D., Sparks C.E. Apolipoprotein B mRNA and lipoprotein secretion are increased in McArdle RH-7777 cells by expression of betaine-homocysteine S-methyltransferase. Biochem. J. 341(Pt 3):1999;639-645.
19. Millian N.S., Garrow T.A. Human betaine-homocysteine methyltransferase is a zinc metalloenzyme. Arch. Biochem. Biophys. 356:1998;93-98.
20. Sunden S.L.F., Renduchintala M.S., Park E.I., Miklasz S.D., Garrow T.A. Betaine-homocysteine methyltransferase expression in porcine and human tissues and chromosomal localization of the human gene. Arch. Biochem. Biophys. 345:1997;171-174.
21. Varela-Moreiras G., Alonso-Aperte E., Rubio M., Gasso M., Deulofeu R., Alvarez L., Caballeria J., Rodes J., Mato J.M. Carbon tetrachloride-induced hepatic injury is associated with global DNA hypomethylation and homocysteinemia: effect of S-adenosylmethionine treatment. Hepatology. 22:1995;1310-1315.
22. Trimble K.C., Molloy A.M., Scott J.M., Weir D.G. The effect of ethanol on one-carbon metabolism: increased methionine catabolism and lipotrope methyl-group wastage. Hepatology. 18:1993;984-989.
23. Barak A.J., Beckenhauer H.C., Tuma D.J. Betaine, ethanol, and the liver: a review. Alcohol. 13:1996;395-398.
24. Bosy-Westphal A., Petersen S., Hinrichsen H., Czech N., Muller J. Increased plasma homocysteine in liver cirrhosis. Hepatol. Res. 20:2001;28-38.
25. Garcia-Tevijano E.R., Berasain C., Rodriguez J.A., Corrales F.J., Arias R., Martin-Duce A., Caballeria J., Mato J.M., Avila M.A. Hyperhomocysteinemia in liver cirrhosis: mechanisms and role in vascular and hepatic fibrosis. Hypertension. 38:2001;1217-1221.
26. Lieber C.S., Casini A., DeCarli L.M., Kim C.I., Lowe N., Sasaki R., Leo M.A. S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon. Hepatology. 11:1990;165-172.
27. Corrales F., Gimenez A., Alvarez L., Caballeria J., Pajares M.A., Andreu H., Pares A., Mato J.M., Rodes J. S-adenosylmethionine treatment prevents carbon tetrachloride-induced S-adenosylmethionine synthetase inactivation and attenuates liver injury. Hepatology. 16:1992;1022-1027.
28. Garcia-Ruiz C., Morales A., Colell A., Ballesta A., Rodes J., Kaplowitz N., Fernandez-Checa J.C. Feeding S-adenosyl-L-methionine attenuates both ethanol-induced depletion of mitochondrial glutathione and mitochondrial dysfunction in periportal and perivenous rat hepatocytes. Hepatology. 21:1995;207-214.
29. Bray G.P., Tredger J.M., Williams R. S-adenosylmethionine protects against acetaminophen hepatotoxicity in two mouse models. Hepatology. 15:1992;297-301.
30. Pascale R.M., Marras V., Simile M.M., Daino L., Pinna G., Bennati S., Carta M., Seddaiu M.A., Massarelli G., Feo F. Chemoprevention of rat liver carcinogenesis by S-adenosyl-L-methionine: a long-term study. Cancer Res. 52:1992;4979-4986.
31. Chawla R.K., Bonkovsky H.L., Galambos J.T. Biochemistry and pharmacology of S-adenosyl-L-methionine and rationale for its use in liver disease. Drugs. 40(Suppl. 3):1990;98-110.
32. Avila M.A., Berasain C., Torres L., Martin-Duce A., Corrales F.J., Yang H., Prieto J., Lu S.C., Caballeria J., Rodes J., Mato J.M. Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. J. Hepatol. 33:2000;907-914.
33. Malinow M.R. Plasma homocyst(e)ine and arterial occlusive diseases: a mini-review. Clin. Chem. 41:1995;173-176.
34. Jakubowski H. Metabolism of homocysteine thiolactone in human cell cultures. Possible mechanism for pathological consequences of elevated homocysteine levels. J. Biol. Chem. 272:1997;1935-1942.
35. Torres L., Garcia-Trevijano E.R., Rodriguez J.A., Carretero M.V., Bustos M., Fernandez E., Eguinoa E., Mato J.M., Avila M.A. Induction of TIMP-1 expression in rat hepatic stellate cells and hepatocytes: a new role for homocysteine in liver fibrosis. Biochim. Biophys. Acta. 1455:1999;12-22.